Prohibits the ownership, operation or control of pharmacies directly or indirectly by pharmacy benefit managers.
Summary
Bill A06546 seeks to amend the education law in New York by prohibiting pharmacy benefit managers (PBMs) from owning, operating, or controlling pharmacies, either directly or indirectly. The bill aims to ensure that the operations of pharmacies remain independent from the influence of PBMs, which are entities that manage prescription drug benefits on behalf of health insurers. This legislation is intended to promote transparency and fairness in the pharmacy sector, potentially leading to better outcomes for consumers.
Impact
If enacted, this bill would significantly alter the relationship between pharmacies and pharmacy benefit managers in New York. It would require any existing ownership structures that violate this provision to divest within three years. This change could lead to a restructuring of how pharmacies operate and interact with PBMs, potentially impacting pricing, availability of medications, and the overall healthcare landscape in the state.
Sentiment
The sentiment surrounding Bill A06546 appears to be cautiously supportive among proponents who argue that it will enhance consumer protection and reduce conflicts of interest in the pharmacy sector. However, there may be concerns from pharmacy benefit managers and some healthcare stakeholders about the implications for their business models and the potential for increased costs or reduced access to medications for consumers.
Contention
Notable points of contention include the potential economic impact on pharmacy benefit managers, who may argue that this bill could limit their ability to negotiate prices and manage drug benefits effectively. Additionally, some pharmacy owners may express concerns about the financial implications of divesting from PBM ownership, while advocates for the bill emphasize the need for greater independence in pharmacy operations to protect consumer interests.
Provides for fair pharmacy reimbursement from a pharmacy benefit manager, and also provides anti-discrimination prohibitions in regard to non-affiliated pharmacies or pharmacists.
Provides for fair pharmacy reimbursement from a pharmacy benefit manager, and also provides anti-discrimination prohibitions in regard to non-affiliated pharmacies or pharmacists.
Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers.